Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (521-530 of 611) with videos related to

Pageof 62
Sort By:
JAMA Network Open|January 10, 2025
Attributable Risk and Consequences of Bone Mineral Density Deficits in Childhood Cancer SurvivorsChelsea G Goodenough, Jessica L Baedke, Angela M Delaney, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 2026
Characterization of Genetic Etiological Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship CohortsXiaoxi Meng, Cheng Chen, Na Qin, et al.
Scientific Reports|July 23, 2020
FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemiaSung-Liang Yu, Hui Zhang, Bing-Ching Ho, et al.
Blood|January 10, 2025
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemiaCarolin S Escherich, Takaya Moriyama, Zhenhua Li, et al.
Leukemia|November 24, 2023
Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in ChinaKam Tong Leung, Jiaoyang Cai, Yu Liu, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
The New England Journal of Medicine|June 26, 2009
Treating childhood acute lymphoblastic leukemia without cranial irradiationChing-Hon Pui, Dario Campana, Deqing Pei, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemiaHeng Xu, Cheng Cheng, Meenakshi Devidas, et al.
Nature Genetics|February 8, 2011
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
Pageof 62

Showing results (521-530 of 611) with videos related to

Sort By:
Pageof 62
JAMA Network Open|January 10, 2025
Attributable Risk and Consequences of Bone Mineral Density Deficits in Childhood Cancer SurvivorsChelsea G Goodenough, Jessica L Baedke, Angela M Delaney, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 2026
Characterization of Genetic Etiological Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship CohortsXiaoxi Meng, Cheng Chen, Na Qin, et al.
Scientific Reports|July 23, 2020
FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemiaSung-Liang Yu, Hui Zhang, Bing-Ching Ho, et al.
Blood|January 10, 2025
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemiaCarolin S Escherich, Takaya Moriyama, Zhenhua Li, et al.
Leukemia|November 24, 2023
Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in ChinaKam Tong Leung, Jiaoyang Cai, Yu Liu, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
The New England Journal of Medicine|June 26, 2009
Treating childhood acute lymphoblastic leukemia without cranial irradiationChing-Hon Pui, Dario Campana, Deqing Pei, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemiaHeng Xu, Cheng Cheng, Meenakshi Devidas, et al.
Nature Genetics|February 8, 2011
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
Pageof 62